Journal article
Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor
- Abstract:
- A potent inhibitor of the JmjC histone lysine demethylase KDM2A (compound 35, pIC50 7.2) with excellent selectivity over representatives from other KDM subfamilies has been developed; the discovery that a triazolopyridine compound binds to the active site of JmjC KDMs was followed by optimisation of the triazole substituent for KDM2A inhibition and selectivity. This journal is
- Publication status:
- Published
Actions
Access Document
- Publisher copy:
- 10.1039/c4md00291a
Authors
- Publisher:
- Royal Society of Chemistry
- Journal:
- MEDCHEMCOMM More from this journal
- Volume:
- 5
- Issue:
- 12
- Pages:
- 1879-1886
- Publication date:
- 2014-01-01
- DOI:
- EISSN:
-
2040-2511
- ISSN:
-
2040-2503
- Language:
-
English
- Pubs id:
-
pubs:492501
- UUID:
-
uuid:c8e6bc5c-c1a6-4979-89ab-3e329b8a4b44
- Local pid:
-
pubs:492501
- Source identifiers:
-
492501
- Deposit date:
-
2014-12-19
- ARK identifier:
Terms of use
- Copyright date:
- 2014
If you are the owner of this record, you can report an update to it here: Report update to this record